n in companies with platform technologies applicable to global health. BMGF's biotech portfolio includes five biotech companies: Liquidia, Genocea, Vistena, Atn.va and Anacor. At BMGF, Boris also led discovery program of novel diagnostics platform technologies, molecular diagnostics point-of-care applic